MacroGenics, Inc.
MGNX
$3.08
-$0.02-0.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.31% | -9.70% | 303.47% | 255.31% | 155.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.31% | -9.70% | 303.47% | 255.31% | 155.26% |
| Cost of Revenue | -3.33% | -4.75% | -1.15% | 40.69% | 41.65% |
| Gross Profit | 14.79% | -8.87% | 88.72% | 63.67% | 47.31% |
| SG&A Expenses | -44.88% | 3.48% | 14.48% | 25.64% | 36.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.66% | -2.90% | 2.40% | 11.71% | 14.78% |
| Operating Income | 34.12% | -6.06% | 60.35% | 45.82% | 34.28% |
| Income Before Tax | -14.04% | 23.34% | 74.08% | -136.10% | -628.88% |
| Income Tax Expenses | -171.19% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.43% | 22.26% | 73.31% | -140.17% | -639.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.43% | 22.26% | 73.31% | -140.17% | -639.30% |
| EBIT | 34.12% | -6.06% | 60.35% | 45.82% | 34.28% |
| EBITDA | 36.26% | -6.37% | 62.77% | 47.46% | 35.03% |
| EPS Basic | -10.17% | 23.28% | 73.73% | -141.03% | -637.84% |
| Normalized Basic EPS | 27.05% | -12.39% | 48.08% | -293.49% | -1,024.18% |
| EPS Diluted | -9.79% | 23.22% | 73.64% | -132.17% | -568.38% |
| Normalized Diluted EPS | 27.11% | -12.29% | 48.03% | -286.91% | -975.74% |
| Average Basic Shares Outstanding | 0.85% | 0.95% | 1.06% | 1.19% | 1.12% |
| Average Diluted Shares Outstanding | 0.82% | 0.92% | 1.01% | 0.98% | 0.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |